Showing results (211-220 of 636) with videos related to

Sort By:
Pageof 64
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2025
TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancerNuno Padrão, Sebastian Gregoricchio, Nils Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell CountsJacqueline A Shaw, David S Guttery, Allison Hills, et al.
Molecular Cell|November 17, 2023
Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibitionGemma A Wilson, Karla Vuina, Georgina Sava, et al.
Oncogene|November 24, 2023
Selective inhibition of CDK9 in triple negative breast cancerEbtihal H Mustafa, Geraldine Laven-Law, Zoya Kikhtyak, et al.
Anti-Cancer Drugs|December 13, 2024
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancerCaroline H Rinderle, Christopher V Baker, Courtney B Lagarde, et al.
British Journal of Cancer|September 28, 2019
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancerChitra Joseph, Sara Al-Izzi, Mansour Alsaleem, et al.
Tuberculosis (Edinburgh, Scotland)|December 24, 2014
Utility of propidium monoazide viability assay as a biomarker for a tuberculosis diseaseVladyslav Nikolayevskyy, Paolo Miotto, Edita Pimkina, et al.
ACS Omega|April 28, 2025
Synthesis of BaSiH<sub>6</sub> Hydridosilicate at High Pressures-A Bridge to BaSiH<sub>8</sub> PolyhydrideDoreen C Beyer, Kristina Spektor, Olga Yu Vekilova, et al.
Scientific Reports|March 14, 2020
A novel hotspot specific isothermal amplification method for detection of the common PIK3CA p.H1047R breast cancer mutationMelpomeni Kalofonou, Kenny Malpartida-Cardenas, George Alexandrou, et al.
Pageof 64